What is the current valuation of the Veterinary CBD Market?

The Veterinary CBD Market was valued at approximately 871.06 USD Million in 2024. Read More

What is the projected market size for the Veterinary CBD Market by 2035?

The market is projected to reach around 1720.08 USD Million by 2035. Read More

What is the expected CAGR for the Veterinary CBD Market during the forecast period?

The expected CAGR for the Veterinary CBD Market from 2025 to 2035 is 6.34%. Read More

Which companies are considered key players in the Veterinary CBD Market?

Key players in the market include Pet Releaf, Canna-Pet, HolistaPet, King Kanine, VetCBD, Paw CBD, CBD Dog Health, and Pure Paws. Read More

What are the primary applications of Veterinary CBD products?

The primary applications include Pain Management, Anxiety Relief, Anti-Inflammatory, Seizure Control, and Appetite Stimulation. Read More

How do Veterinary Clinics and Pet Owners contribute to the market?

Veterinary Clinics and Pet Owners are significant contributors, with market segments valued between 200.0 to 600.0 USD Million. Read More

What types of formulations are available in the Veterinary CBD Market?

Formulations include Oils, Treats, Capsules, Topicals, and Powders, with Treats valued between 250.0 to 500.0 USD Million. Read More

Which animal types are primarily targeted by Veterinary CBD products?

The primary animal types include Dogs, Cats, Horses, Rabbits, and Exotic Pets, with Dogs leading the segment valued between 300.0 to 600.0 USD Million. Read More

What distribution channels are utilized in the Veterinary CBD Market?

Distribution channels include Online Sales, Retail Stores, Veterinary Clinics, Wholesale Distributors, and E-commerce Platforms. Read More

What is the market outlook for Veterinary CBD products in the coming years?

The market outlook appears positive, with a projected growth trajectory leading to an estimated valuation of 1720.08 USD Million by 2035. Read More

Veterinary CBD Market

ID: MRFR/HC/6666-HCR

111 Pages

Vikita Thakur

Last Updated: May 15, 2026

Veterinary CBD Market Research Report Insights and Industry Analysis by Source (Marijuana-Derived, Hemp-Derived); Product (Food-Grade, Therapeutic-Grade, Personal Care); Distribution Channel (E-Commerce, Retail Pharmacies, Vetcare Clinics) and Regions, Competitive Market Size, Share, Trends, and Forecast - 2035

Summary Table of Contents Segmentation Methodology Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Healthcare, BY Application (USD Million)
  1. 4.1.1 Pain Management
  2. 4.1.2 Anxiety Relief
  3. 4.1.3 Anti-Inflammatory
  4. 4.1.4 Seizure Control
  5. 4.1.5 Appetite Stimulation
2. 4.2 Healthcare, BY End Use (USD Million)
  1. 4.2.1 Veterinary Clinics
  2. 4.2.2 Pet Owners
  3. 4.2.3 Animal Shelters
  4. 4.2.4 Research Institutions
  5. 4.2.5 Online Retailers
3. 4.3 Healthcare, BY Formulation Type (USD Million)
  1. 4.3.1 Oils
  2. 4.3.2 Treats
  3. 4.3.3 Capsules
  4. 4.3.4 Topicals
  5. 4.3.5 Powders
4. 4.4 Healthcare, BY Animal Type (USD Million)
  1. 4.4.1 Dogs
  2. 4.4.2 Cats
  3. 4.4.3 Horses
  4. 4.4.4 Rabbits
  5. 4.4.5 Exotic Pets
5. 4.5 Healthcare, BY Distribution Channel (USD Million)
  1. 4.5.1 Online Sales
  2. 4.5.2 Retail Stores
  3. 4.5.3 Veterinary Clinics
  4. 4.5.4 Wholesale Distributors
  5. 4.5.5 E-commerce Platforms
6. 4.6 Healthcare, BY Region (USD Million)
  1. 4.6.1 North America
    1. 4.6.1.1 US
    2. 4.6.1.2 Canada
  2. 4.6.2 Europe
    1. 4.6.2.1 Germany
    2. 4.6.2.2 UK
    3. 4.6.2.3 France
    4. 4.6.2.4 Russia
    5. 4.6.2.5 Italy
    6. 4.6.2.6 Spain
    7. 4.6.2.7 Rest of Europe
  3. 4.6.3 APAC
    1. 4.6.3.1 China
    2. 4.6.3.2 India
    3. 4.6.3.3 Japan
    4. 4.6.3.4 South Korea
    5. 4.6.3.5 Malaysia
    6. 4.6.3.6 Thailand
    7. 4.6.3.7 Indonesia
    8. 4.6.3.8 Rest of APAC
  4. 4.6.4 South America
    1. 4.6.4.1 Brazil
    2. 4.6.4.2 Mexico
    3. 4.6.4.3 Argentina
    4. 4.6.4.4 Rest of South America
  5. 4.6.5 MEA
    1. 4.6.5.1 GCC Countries
    2. 4.6.5.2 South Africa
    3. 4.6.5.3 Rest of MEA
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Healthcare
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Pet Releaf (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Canna-Pet (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 HolistaPet (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 King Kanine (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 VetCBD (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Paw CBD (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 CBD Dog Health (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Pure Paws (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 NORTH AMERICA MARKET ANALYSIS
3. 6.3 US MARKET ANALYSIS BY APPLICATION
4. 6.4 US MARKET ANALYSIS BY END USE
5. 6.5 US MARKET ANALYSIS BY FORMULATION TYPE
6. 6.6 US MARKET ANALYSIS BY ANIMAL TYPE
7. 6.7 US MARKET ANALYSIS BY DISTRIBUTION CHANNEL
8. 6.8 CANADA MARKET ANALYSIS BY APPLICATION
9. 6.9 CANADA MARKET ANALYSIS BY END USE
10. 6.10 CANADA MARKET ANALYSIS BY FORMULATION TYPE
11. 6.11 CANADA MARKET ANALYSIS BY ANIMAL TYPE
12. 6.12 CANADA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
13. 6.13 EUROPE MARKET ANALYSIS
14. 6.14 GERMANY MARKET ANALYSIS BY APPLICATION
15. 6.15 GERMANY MARKET ANALYSIS BY END USE
16. 6.16 GERMANY MARKET ANALYSIS BY FORMULATION TYPE
17. 6.17 GERMANY MARKET ANALYSIS BY ANIMAL TYPE
18. 6.18 GERMANY MARKET ANALYSIS BY DISTRIBUTION CHANNEL
19. 6.19 UK MARKET ANALYSIS BY APPLICATION
20. 6.20 UK MARKET ANALYSIS BY END USE
21. 6.21 UK MARKET ANALYSIS BY FORMULATION TYPE
22. 6.22 UK MARKET ANALYSIS BY ANIMAL TYPE
23. 6.23 UK MARKET ANALYSIS BY DISTRIBUTION CHANNEL
24. 6.24 FRANCE MARKET ANALYSIS BY APPLICATION
25. 6.25 FRANCE MARKET ANALYSIS BY END USE
26. 6.26 FRANCE MARKET ANALYSIS BY FORMULATION TYPE
27. 6.27 FRANCE MARKET ANALYSIS BY ANIMAL TYPE
28. 6.28 FRANCE MARKET ANALYSIS BY DISTRIBUTION CHANNEL
29. 6.29 RUSSIA MARKET ANALYSIS BY APPLICATION
30. 6.30 RUSSIA MARKET ANALYSIS BY END USE
31. 6.31 RUSSIA MARKET ANALYSIS BY FORMULATION TYPE
32. 6.32 RUSSIA MARKET ANALYSIS BY ANIMAL TYPE
33. 6.33 RUSSIA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
34. 6.34 ITALY MARKET ANALYSIS BY APPLICATION
35. 6.35 ITALY MARKET ANALYSIS BY END USE
36. 6.36 ITALY MARKET ANALYSIS BY FORMULATION TYPE
37. 6.37 ITALY MARKET ANALYSIS BY ANIMAL TYPE
38. 6.38 ITALY MARKET ANALYSIS BY DISTRIBUTION CHANNEL
39. 6.39 SPAIN MARKET ANALYSIS BY APPLICATION
40. 6.40 SPAIN MARKET ANALYSIS BY END USE
41. 6.41 SPAIN MARKET ANALYSIS BY FORMULATION TYPE
42. 6.42 SPAIN MARKET ANALYSIS BY ANIMAL TYPE
43. 6.43 SPAIN MARKET ANALYSIS BY DISTRIBUTION CHANNEL
44. 6.44 REST OF EUROPE MARKET ANALYSIS BY APPLICATION
45. 6.45 REST OF EUROPE MARKET ANALYSIS BY END USE
46. 6.46 REST OF EUROPE MARKET ANALYSIS BY FORMULATION TYPE
47. 6.47 REST OF EUROPE MARKET ANALYSIS BY ANIMAL TYPE
48. 6.48 REST OF EUROPE MARKET ANALYSIS BY DISTRIBUTION CHANNEL
49. 6.49 APAC MARKET ANALYSIS
50. 6.50 CHINA MARKET ANALYSIS BY APPLICATION
51. 6.51 CHINA MARKET ANALYSIS BY END USE
52. 6.52 CHINA MARKET ANALYSIS BY FORMULATION TYPE
53. 6.53 CHINA MARKET ANALYSIS BY ANIMAL TYPE
54. 6.54 CHINA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
55. 6.55 INDIA MARKET ANALYSIS BY APPLICATION
56. 6.56 INDIA MARKET ANALYSIS BY END USE
57. 6.57 INDIA MARKET ANALYSIS BY FORMULATION TYPE
58. 6.58 INDIA MARKET ANALYSIS BY ANIMAL TYPE
59. 6.59 INDIA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
60. 6.60 JAPAN MARKET ANALYSIS BY APPLICATION
61. 6.61 JAPAN MARKET ANALYSIS BY END USE
62. 6.62 JAPAN MARKET ANALYSIS BY FORMULATION TYPE
63. 6.63 JAPAN MARKET ANALYSIS BY ANIMAL TYPE
64. 6.64 JAPAN MARKET ANALYSIS BY DISTRIBUTION CHANNEL
65. 6.65 SOUTH KOREA MARKET ANALYSIS BY APPLICATION
66. 6.66 SOUTH KOREA MARKET ANALYSIS BY END USE
67. 6.67 SOUTH KOREA MARKET ANALYSIS BY FORMULATION TYPE
68. 6.68 SOUTH KOREA MARKET ANALYSIS BY ANIMAL TYPE
69. 6.69 SOUTH KOREA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
70. 6.70 MALAYSIA MARKET ANALYSIS BY APPLICATION
71. 6.71 MALAYSIA MARKET ANALYSIS BY END USE
72. 6.72 MALAYSIA MARKET ANALYSIS BY FORMULATION TYPE
73. 6.73 MALAYSIA MARKET ANALYSIS BY ANIMAL TYPE
74. 6.74 MALAYSIA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
75. 6.75 THAILAND MARKET ANALYSIS BY APPLICATION
76. 6.76 THAILAND MARKET ANALYSIS BY END USE
77. 6.77 THAILAND MARKET ANALYSIS BY FORMULATION TYPE
78. 6.78 THAILAND MARKET ANALYSIS BY ANIMAL TYPE
79. 6.79 THAILAND MARKET ANALYSIS BY DISTRIBUTION CHANNEL
80. 6.80 INDONESIA MARKET ANALYSIS BY APPLICATION
81. 6.81 INDONESIA MARKET ANALYSIS BY END USE
82. 6.82 INDONESIA MARKET ANALYSIS BY FORMULATION TYPE
83. 6.83 INDONESIA MARKET ANALYSIS BY ANIMAL TYPE
84. 6.84 INDONESIA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
85. 6.85 REST OF APAC MARKET ANALYSIS BY APPLICATION
86. 6.86 REST OF APAC MARKET ANALYSIS BY END USE
87. 6.87 REST OF APAC MARKET ANALYSIS BY FORMULATION TYPE
88. 6.88 REST OF APAC MARKET ANALYSIS BY ANIMAL TYPE
89. 6.89 REST OF APAC MARKET ANALYSIS BY DISTRIBUTION CHANNEL
90. 6.90 SOUTH AMERICA MARKET ANALYSIS
91. 6.91 BRAZIL MARKET ANALYSIS BY APPLICATION
92. 6.92 BRAZIL MARKET ANALYSIS BY END USE
93. 6.93 BRAZIL MARKET ANALYSIS BY FORMULATION TYPE
94. 6.94 BRAZIL MARKET ANALYSIS BY ANIMAL TYPE
95. 6.95 BRAZIL MARKET ANALYSIS BY DISTRIBUTION CHANNEL
96. 6.96 MEXICO MARKET ANALYSIS BY APPLICATION
97. 6.97 MEXICO MARKET ANALYSIS BY END USE
98. 6.98 MEXICO MARKET ANALYSIS BY FORMULATION TYPE
99. 6.99 MEXICO MARKET ANALYSIS BY ANIMAL TYPE
100. 6.100 MEXICO MARKET ANALYSIS BY DISTRIBUTION CHANNEL
101. 6.101 ARGENTINA MARKET ANALYSIS BY APPLICATION
102. 6.102 ARGENTINA MARKET ANALYSIS BY END USE
103. 6.103 ARGENTINA MARKET ANALYSIS BY FORMULATION TYPE
104. 6.104 ARGENTINA MARKET ANALYSIS BY ANIMAL TYPE
105. 6.105 ARGENTINA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
106. 6.106 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
107. 6.107 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USE
108. 6.108 REST OF SOUTH AMERICA MARKET ANALYSIS BY FORMULATION TYPE
109. 6.109 REST OF SOUTH AMERICA MARKET ANALYSIS BY ANIMAL TYPE
110. 6.110 REST OF SOUTH AMERICA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
111. 6.111 MEA MARKET ANALYSIS
112. 6.112 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION
113. 6.113 GCC COUNTRIES MARKET ANALYSIS BY END USE
114. 6.114 GCC COUNTRIES MARKET ANALYSIS BY FORMULATION TYPE
115. 6.115 GCC COUNTRIES MARKET ANALYSIS BY ANIMAL TYPE
116. 6.116 GCC COUNTRIES MARKET ANALYSIS BY DISTRIBUTION CHANNEL
117. 6.117 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION
118. 6.118 SOUTH AFRICA MARKET ANALYSIS BY END USE
119. 6.119 SOUTH AFRICA MARKET ANALYSIS BY FORMULATION TYPE
120. 6.120 SOUTH AFRICA MARKET ANALYSIS BY ANIMAL TYPE
121. 6.121 SOUTH AFRICA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
122. 6.122 REST OF MEA MARKET ANALYSIS BY APPLICATION
123. 6.123 REST OF MEA MARKET ANALYSIS BY END USE
124. 6.124 REST OF MEA MARKET ANALYSIS BY FORMULATION TYPE
125. 6.125 REST OF MEA MARKET ANALYSIS BY ANIMAL TYPE
126. 6.126 REST OF MEA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
127. 6.127 KEY BUYING CRITERIA OF HEALTHCARE
128. 6.128 RESEARCH PROCESS OF MRFR
129. 6.129 DRO ANALYSIS OF HEALTHCARE
130. 6.130 DRIVERS IMPACT ANALYSIS: HEALTHCARE
131. 6.131 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
132. 6.132 SUPPLY / VALUE CHAIN: HEALTHCARE
133. 6.133 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
134. 6.134 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Million)
135. 6.135 HEALTHCARE, BY END USE, 2024 (% SHARE)
136. 6.136 HEALTHCARE, BY END USE, 2024 TO 2035 (USD Million)
137. 6.137 HEALTHCARE, BY FORMULATION TYPE, 2024 (% SHARE)
138. 6.138 HEALTHCARE, BY FORMULATION TYPE, 2024 TO 2035 (USD Million)
139. 6.139 HEALTHCARE, BY ANIMAL TYPE, 2024 (% SHARE)
140. 6.140 HEALTHCARE, BY ANIMAL TYPE, 2024 TO 2035 (USD Million)
141. 6.141 HEALTHCARE, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
142. 6.142 HEALTHCARE, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Million)
143. 6.143 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 North America MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.2.2 BY END USE, 2025-2035 (USD Million)
  3. 7.2.3 BY FORMULATION TYPE, 2025-2035 (USD Million)
  4. 7.2.4 BY ANIMAL TYPE, 2025-2035 (USD Million)
  5. 7.2.5 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Million)
2. 7.3 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.3.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.3.2 BY END USE, 2025-2035 (USD Million)
  3. 7.3.3 BY FORMULATION TYPE, 2025-2035 (USD Million)
  4. 7.3.4 BY ANIMAL TYPE, 2025-2035 (USD Million)
  5. 7.3.5 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Million)
3. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  1. 7.4.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.4.2 BY END USE, 2025-2035 (USD Million)
  3. 7.4.3 BY FORMULATION TYPE, 2025-2035 (USD Million)
  4. 7.4.4 BY ANIMAL TYPE, 2025-2035 (USD Million)
  5. 7.4.5 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Million)
4. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.5.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.5.2 BY END USE, 2025-2035 (USD Million)
  3. 7.5.3 BY FORMULATION TYPE, 2025-2035 (USD Million)
  4. 7.5.4 BY ANIMAL TYPE, 2025-2035 (USD Million)
  5. 7.5.5 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Million)
5. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  1. 7.6.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.6.2 BY END USE, 2025-2035 (USD Million)
  3. 7.6.3 BY FORMULATION TYPE, 2025-2035 (USD Million)
  4. 7.6.4 BY ANIMAL TYPE, 2025-2035 (USD Million)
  5. 7.6.5 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Million)
6. 7.7 UK MARKET SIZE ESTIMATES; FORECAST
  1. 7.7.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.7.2 BY END USE, 2025-2035 (USD Million)
  3. 7.7.3 BY FORMULATION TYPE, 2025-2035 (USD Million)
  4. 7.7.4 BY ANIMAL TYPE, 2025-2035 (USD Million)
  5. 7.7.5 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Million)
7. 7.8 France MARKET SIZE ESTIMATES; FORECAST
  1. 7.8.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.8.2 BY END USE, 2025-2035 (USD Million)
  3. 7.8.3 BY FORMULATION TYPE, 2025-2035 (USD Million)
  4. 7.8.4 BY ANIMAL TYPE, 2025-2035 (USD Million)
  5. 7.8.5 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Million)
8. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  1. 7.9.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.9.2 BY END USE, 2025-2035 (USD Million)
  3. 7.9.3 BY FORMULATION TYPE, 2025-2035 (USD Million)
  4. 7.9.4 BY ANIMAL TYPE, 2025-2035 (USD Million)
  5. 7.9.5 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Million)
9. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  1. 7.10.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.10.2 BY END USE, 2025-2035 (USD Million)
  3. 7.10.3 BY FORMULATION TYPE, 2025-2035 (USD Million)
  4. 7.10.4 BY ANIMAL TYPE, 2025-2035 (USD Million)
  5. 7.10.5 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Million)
10. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  1. 7.11.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.11.2 BY END USE, 2025-2035 (USD Million)
  3. 7.11.3 BY FORMULATION TYPE, 2025-2035 (USD Million)
  4. 7.11.4 BY ANIMAL TYPE, 2025-2035 (USD Million)
  5. 7.11.5 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Million)
11. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.12.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.12.2 BY END USE, 2025-2035 (USD Million)
  3. 7.12.3 BY FORMULATION TYPE, 2025-2035 (USD Million)
  4. 7.12.4 BY ANIMAL TYPE, 2025-2035 (USD Million)
  5. 7.12.5 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Million)
12. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.13.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.13.2 BY END USE, 2025-2035 (USD Million)
  3. 7.13.3 BY FORMULATION TYPE, 2025-2035 (USD Million)
  4. 7.13.4 BY ANIMAL TYPE, 2025-2035 (USD Million)
  5. 7.13.5 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Million)
13. 7.14 China MARKET SIZE ESTIMATES; FORECAST
  1. 7.14.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.14.2 BY END USE, 2025-2035 (USD Million)
  3. 7.14.3 BY FORMULATION TYPE, 2025-2035 (USD Million)
  4. 7.14.4 BY ANIMAL TYPE, 2025-2035 (USD Million)
  5. 7.14.5 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Million)
14. 7.15 India MARKET SIZE ESTIMATES; FORECAST
  1. 7.15.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.15.2 BY END USE, 2025-2035 (USD Million)
  3. 7.15.3 BY FORMULATION TYPE, 2025-2035 (USD Million)
  4. 7.15.4 BY ANIMAL TYPE, 2025-2035 (USD Million)
  5. 7.15.5 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Million)
15. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  1. 7.16.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.16.2 BY END USE, 2025-2035 (USD Million)
  3. 7.16.3 BY FORMULATION TYPE, 2025-2035 (USD Million)
  4. 7.16.4 BY ANIMAL TYPE, 2025-2035 (USD Million)
  5. 7.16.5 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Million)
16. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  1. 7.17.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.17.2 BY END USE, 2025-2035 (USD Million)
  3. 7.17.3 BY FORMULATION TYPE, 2025-2035 (USD Million)
  4. 7.17.4 BY ANIMAL TYPE, 2025-2035 (USD Million)
  5. 7.17.5 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Million)
17. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  1. 7.18.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.18.2 BY END USE, 2025-2035 (USD Million)
  3. 7.18.3 BY FORMULATION TYPE, 2025-2035 (USD Million)
  4. 7.18.4 BY ANIMAL TYPE, 2025-2035 (USD Million)
  5. 7.18.5 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Million)
18. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  1. 7.19.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.19.2 BY END USE, 2025-2035 (USD Million)
  3. 7.19.3 BY FORMULATION TYPE, 2025-2035 (USD Million)
  4. 7.19.4 BY ANIMAL TYPE, 2025-2035 (USD Million)
  5. 7.19.5 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Million)
19. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  1. 7.20.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.20.2 BY END USE, 2025-2035 (USD Million)
  3. 7.20.3 BY FORMULATION TYPE, 2025-2035 (USD Million)
  4. 7.20.4 BY ANIMAL TYPE, 2025-2035 (USD Million)
  5. 7.20.5 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Million)
20. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.21.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.21.2 BY END USE, 2025-2035 (USD Million)
  3. 7.21.3 BY FORMULATION TYPE, 2025-2035 (USD Million)
  4. 7.21.4 BY ANIMAL TYPE, 2025-2035 (USD Million)
  5. 7.21.5 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Million)
21. 7.22 South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.22.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.22.2 BY END USE, 2025-2035 (USD Million)
  3. 7.22.3 BY FORMULATION TYPE, 2025-2035 (USD Million)
  4. 7.22.4 BY ANIMAL TYPE, 2025-2035 (USD Million)
  5. 7.22.5 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Million)
22. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  1. 7.23.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.23.2 BY END USE, 2025-2035 (USD Million)
  3. 7.23.3 BY FORMULATION TYPE, 2025-2035 (USD Million)
  4. 7.23.4 BY ANIMAL TYPE, 2025-2035 (USD Million)
  5. 7.23.5 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Million)
23. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  1. 7.24.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.24.2 BY END USE, 2025-2035 (USD Million)
  3. 7.24.3 BY FORMULATION TYPE, 2025-2035 (USD Million)
  4. 7.24.4 BY ANIMAL TYPE, 2025-2035 (USD Million)
  5. 7.24.5 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Million)
24. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  1. 7.25.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.25.2 BY END USE, 2025-2035 (USD Million)
  3. 7.25.3 BY FORMULATION TYPE, 2025-2035 (USD Million)
  4. 7.25.4 BY ANIMAL TYPE, 2025-2035 (USD Million)
  5. 7.25.5 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Million)
25. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.26.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.26.2 BY END USE, 2025-2035 (USD Million)
  3. 7.26.3 BY FORMULATION TYPE, 2025-2035 (USD Million)
  4. 7.26.4 BY ANIMAL TYPE, 2025-2035 (USD Million)
  5. 7.26.5 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Million)
26. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.27.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.27.2 BY END USE, 2025-2035 (USD Million)
  3. 7.27.3 BY FORMULATION TYPE, 2025-2035 (USD Million)
  4. 7.27.4 BY ANIMAL TYPE, 2025-2035 (USD Million)
  5. 7.27.5 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Million)
27. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  1. 7.28.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.28.2 BY END USE, 2025-2035 (USD Million)
  3. 7.28.3 BY FORMULATION TYPE, 2025-2035 (USD Million)
  4. 7.28.4 BY ANIMAL TYPE, 2025-2035 (USD Million)
  5. 7.28.5 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Million)
28. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  1. 7.29.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.29.2 BY END USE, 2025-2035 (USD Million)
  3. 7.29.3 BY FORMULATION TYPE, 2025-2035 (USD Million)
  4. 7.29.4 BY ANIMAL TYPE, 2025-2035 (USD Million)
  5. 7.29.5 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Million)
29. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.30.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.30.2 BY END USE, 2025-2035 (USD Million)
  3. 7.30.3 BY FORMULATION TYPE, 2025-2035 (USD Million)
  4. 7.30.4 BY ANIMAL TYPE, 2025-2035 (USD Million)
  5. 7.30.5 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Million)
30. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.31.1
1. 7.32 ACQUISITION/PARTNERSHIP
7.32.1

Certified Researchers

Customize Report

Veterinary CBD Market Segmentation

Veterinary CBD Market By Application (USD Million, 2025-2035)

Pain Management
Anxiety Relief
Anti-Inflammatory
Seizure Control
Appetite Stimulation

Veterinary CBD Market By End Use (USD Million, 2025-2035)

Veterinary Clinics
Pet Owners
Animal Shelters
Research Institutions
Online Retailers

Veterinary CBD Market By Formulation Type (USD Million, 2025-2035)

Oils
Treats
Capsules
Topicals
Powders

Veterinary CBD Market By Animal Type (USD Million, 2025-2035)

Dogs
Cats
Horses
Rabbits
Exotic Pets

Veterinary CBD Market By Distribution Channel (USD Million, 2025-2035)

Online Sales
Retail Stores
Veterinary Clinics
Wholesale Distributors
E-commerce Platforms

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”